The stock chart for Athersys (NASDAQ: ATHX) is particularly interesting because it is sitting on a solid support level and a bullish cross of the MACD happened recently. The bullish cross has historically been accompanied by an upswing in price per share, which has not happened on this occasion. As such, the chart remains on radar for the support to hold and for the MACD/PPS pattern to repeat itself. Read More

Graft versus Host Disease (GvHD) is an area of great unmet medical that represents a significant risk to cancer patients throughout the world.  The condition occurs when patients receive a bone marrow transplant following radiation and/or chemotherapy, and the transplanted immune cells begin to attack the patient, causing significant pain and disability, or even death. Read More

There’s no arguing that stem cells therapies have been a hot button topic of controversy for years.  The days are few and far between where there isn’t something in the media that highlights some aspect of the debate, whether it’s promising research results; a new clinical study being authorized by the FDA; a high-profile athlete heading overseas for some type of stem cell therapy through the practice of Read More